Advertisement

Why Mesoblast Stock Is Skyrocketing Today

Why Mesoblast Stock Is Skyrocketing Today

What happened Shares of Mesoblast (NASDAQ: MESO) were skyrocketing 49.5% higher as of 11:23 a.m. EDT on Friday. The huge jump came after the Australian biotech announced an FDA advisory committee vote recommending approval of Ryoncil in treating pediatric patients with steroid-refractory acute graft versus host disease (SR-aGVHD).